216 related articles for article (PubMed ID: 20847343)
1. High levels of Hsp90 cochaperone p23 promote tumor progression and poor prognosis in breast cancer by increasing lymph node metastases and drug resistance.
Simpson NE; Lambert WM; Watkins R; Giashuddin S; Huang SJ; Oxelmark E; Arju R; Hochman T; Goldberg JD; Schneider RJ; Reiz LF; Soares FA; Logan SK; Garabedian MJ
Cancer Res; 2010 Nov; 70(21):8446-56. PubMed ID: 20847343
[TBL] [Abstract][Full Text] [Related]
2. Research resource: enhanced genome-wide occupancy of estrogen receptor α by the cochaperone p23 in breast cancer cells.
Simpson NE; Gertz J; Imberg K; Myers RM; Garabedian MJ
Mol Endocrinol; 2012 Jan; 26(1):194-202. PubMed ID: 22074947
[TBL] [Abstract][Full Text] [Related]
3. Role of the HSP90-associated cochaperone p23 in enhancing activity of the androgen receptor and significance for prostate cancer.
Reebye V; Querol Cano L; Lavery DN; Brooke GN; Powell SM; Chotai D; Walker MM; Whitaker HC; Wait R; Hurst HC; Bevan CL
Mol Endocrinol; 2012 Oct; 26(10):1694-706. PubMed ID: 22899854
[TBL] [Abstract][Full Text] [Related]
4. Genetic dissection of p23, an Hsp90 cochaperone, reveals a distinct surface involved in estrogen receptor signaling.
Oxelmark E; Knoblauch R; Arnal S; Su LF; Schapira M; Garabedian MJ
J Biol Chem; 2003 Sep; 278(38):36547-55. PubMed ID: 12835317
[TBL] [Abstract][Full Text] [Related]
5. Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer.
Creighton CJ; Fu X; Hennessy BT; Casa AJ; Zhang Y; Gonzalez-Angulo AM; Lluch A; Gray JW; Brown PH; Hilsenbeck SG; Osborne CK; Mills GB; Lee AV; Schiff R
Breast Cancer Res; 2010; 12(3):R40. PubMed ID: 20569503
[TBL] [Abstract][Full Text] [Related]
6. Novel Hsp90 inhibitor FW-04-806 displays potent antitumor effects in HER2-positive breast cancer cells as a single agent or in combination with lapatinib.
Huang W; Wu QD; Zhang M; Kong YL; Cao PR; Zheng W; Xu JH; Ye M
Cancer Lett; 2015 Jan; 356(2 Pt B):862-71. PubMed ID: 25449780
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
[TBL] [Abstract][Full Text] [Related]
8. Role for Hsp90-associated cochaperone p23 in estrogen receptor signal transduction.
Knoblauch R; Garabedian MJ
Mol Cell Biol; 1999 May; 19(5):3748-59. PubMed ID: 10207098
[TBL] [Abstract][Full Text] [Related]
9. Keratinocyte growth factor (KGF) regulates estrogen receptor-alpha (ER-alpha) expression and cell apoptosis via phosphatidylinositol 3-kinase (PI3K)/Akt pathway in human breast cancer cells.
Chang HL; Sugimoto Y; Liu S; Wang LS; Huang YW; Ye W; Lin YC
Anticancer Res; 2009 Aug; 29(8):3195-205. PubMed ID: 19661335
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific pathways for estrogen regulation of ovarian cancer growth and metastasis.
Spillman MA; Manning NG; Dye WW; Sartorius CA; Post MD; Harrell JC; Jacobsen BM; Horwitz KB
Cancer Res; 2010 Nov; 70(21):8927-36. PubMed ID: 20959477
[TBL] [Abstract][Full Text] [Related]
11. The co-chaperone p23 promotes prostate cancer motility and metastasis.
Cano LQ; Lavery DN; Sin S; Spanjaard E; Brooke GN; Tilman JD; Abroaf A; Gaughan L; Robson CN; Heer R; Mauri F; de Rooij J; Driouch K; Bevan CL
Mol Oncol; 2015 Jan; 9(1):295-308. PubMed ID: 25241147
[TBL] [Abstract][Full Text] [Related]
12. Tosylcyclonovobiocic acids promote cleavage of the hsp90-associated cochaperone p23.
Radanyi C; Le Bras G; Bouclier C; Messaoudi S; Peyrat JF; Brion JD; Alami M; Renoir JM
Biochem Biophys Res Commun; 2009 Feb; 379(2):514-8. PubMed ID: 19118525
[TBL] [Abstract][Full Text] [Related]
13. miRNA mediated up-regulation of cochaperone p23 acts as an anti-apoptotic factor in childhood acute lymphoblastic leukemia.
Liu X; Zou L; Zhu L; Zhang H; Du C; Li Z; Gao C; Zhao X; Bao S; Zheng H
Leuk Res; 2012 Sep; 36(9):1098-104. PubMed ID: 22677230
[TBL] [Abstract][Full Text] [Related]
14. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
15. Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer.
Taylor KJ; Sims AH; Liang L; Faratian D; Muir M; Walker G; Kuske B; Dixon JM; Cameron DA; Harrison DJ; Langdon SP
Breast Cancer Res; 2010; 12(3):R39. PubMed ID: 20569502
[TBL] [Abstract][Full Text] [Related]
16. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
[TBL] [Abstract][Full Text] [Related]
17. Effect of the secretory small GTPase Rab27B on breast cancer growth, invasion, and metastasis.
Hendrix A; Maynard D; Pauwels P; Braems G; Denys H; Van den Broecke R; Lambert J; Van Belle S; Cocquyt V; Gespach C; Bracke M; Seabra MC; Gahl WA; De Wever O; Westbroek W
J Natl Cancer Inst; 2010 Jun; 102(12):866-80. PubMed ID: 20484105
[TBL] [Abstract][Full Text] [Related]
18. A pathway-based approach for identifying biomarkers of tumor progression to trastuzumab-resistant breast cancer.
Nam S; Chang HR; Jung HR; Gim Y; Kim NY; Grailhe R; Seo HR; Park HS; Balch C; Lee J; Park I; Jung SY; Jeong KC; Powis G; Liang H; Lee ES; Ro J; Kim YH
Cancer Lett; 2015 Jan; 356(2 Pt B):880-90. PubMed ID: 25449779
[TBL] [Abstract][Full Text] [Related]
19. Curcumin inhibits nuclear localization of telomerase by dissociating the Hsp90 co-chaperone p23 from hTERT.
Lee JH; Chung IK
Cancer Lett; 2010 Apr; 290(1):76-86. PubMed ID: 19751963
[TBL] [Abstract][Full Text] [Related]
20. Nucleobindin 2 in human breast carcinoma as a potent prognostic factor.
Suzuki S; Takagi K; Miki Y; Onodera Y; Akahira J; Ebata A; Ishida T; Watanabe M; Sasano H; Suzuki T
Cancer Sci; 2012 Jan; 103(1):136-43. PubMed ID: 21988594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
